Atlas Trials

Assessment of Chronic Guillain-Barre Syndrome Improvement With Use of 4-aminopyridine

Clinical trial NCT00056810 · COMPLETED

Trial details

NCT number
NCT00056810
Sponsor
FDA Office of Orphan Products Development
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Guillain-Barre Syndrome
Start date
2002-09-01
Enrollment
30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.